We are building meaningful artificial intelligence that empowers and scales humans to achieve more than ever before

We are putting a blue collar on AI and letting it do what machines do best—leaving the tasks that require creativity, empathy, and passion to people.

Why We’re Different

Artificial Intelligence as a Service (AIaaS)

As a service, CrossChx scopes, builds, implements, and supports your workflows for one price. No working with consultants, integrators or other software companies; we are your single point of contact.

Focus in Healthcare

Since our inception, CrossChx has had a mission to fundamentally change healthcare. This has given us expansive knowledge of healthcare operations, allowing us to design Olive to complete repetitive, data-driven tasks, while clinical team members focus on patient care.

Machine Intelligence

Olive has advanced machine intelligence capabilities, which can be used to enhance bots. As part of the AIaaS model, customers can leverage machine learning models to solve complex problems in their processes. Bots have the ability to learn by collecting data from humans in situations where logic is insufficient.

Based in the United States

CrossChx is based in the United States, with no offshore development. Our incredible team resides in Columbus, Ohio, where Olive is developed and tested.

Leadership

Sean Lane

Sean Lane

CEO and Co-Founder

Bubba Fox

Bubba Fox

Chief Operating Officer

Rebecca Hellmann

Rebecca Hellmann

Chief Marketing Officer

Elizebeth Maag

Elizebeth Maag

General Counsel

Board of Directors

Dr. David Agus

Dr. David Agus

Physician and Professor, USC

Dr. Agus is a professor of medicine and engineering at the University of Southern California (USC) Keck School of Medicine and Viterbi School of Engineering and the CEO and founding director of USC’s Lawrence J. Ellison Institute for Transformative Medicine. He is one of the world’s leading physicians specializing in treating patients with advanced forms of cancer, is the co-founder of several personalized medicine companies and has served in leadership roles at the World Economic Forum. Over the years he has treated a number of high-profile patients, including Steve Jobs and Lance Armstrong. Dr. Agus holds degrees from Princeton University and the University of Pennsylvania School of Medicine.
Sean Lane

Sean Lane

CEO and Co-Founder, CrossChx

Sean is a serial inventor, investor and entrepreneur with a deep background in technology. A former Air Force Intelligence Officer and NSA Fellow, Sean served five tours of duty in Afghanistan and Iraq before founding Battlefield Telecommunications Systems (BTS). Sean has founded technology companies in Ohio, Maryland, and Virginia, and serves as Chairman of the Board of Directors of OmniScience Technology Partners (OSTP), CrossChx, and Lane Capital. A graduate of Miami University with an Honorary Doctorate of Public Service from the University of Rio Grande, Sean was selected as an Ernst and Young Entrepreneur of the Year for Maryland.
Brad Mascho

Brad Mascho

Co-Founder, CrossChx

Brad is a change agent with a mission to fix what is broken and build what does not exist. Prior to founding CrossChx, Brad spent a decade in Washington, DC as a senior advisor to members of the United States Congress and as an executive of a leading insurance association. On Capitol Hill, Brad honed the leadership skills that guide him today, serving as an advisor to CrossChx. An authority on financial management and maximizing efficiency through technological innovation, Brad holds a bachelor’s and a master’s degree from Miami University.
Chris Olsen

Chris Olsen

Partner, Drive Capital

A native of Cincinnati, Chris built his career investing in emerging technology and healthcare companies. Prior to co-founding Drive Capital, Chris was at Sequoia Capital for six years where he led and managed the firm’s growth investing practice. His investments include LitePoint (Teradyne), Klarna, Weebly, Electronic Arts (EA – NASDAQ), GSI Commerce (EBay) and eMeter (Siemens). Before Sequoia, Chris was an investor with Technology Crossover Ventures. Chris briefly dropped out of Yale to compete on the professional squash circuit, where he quickly learned he was better suited to work with entrepreneurs.